Recent studies found that YB-1 overexpression is involved in several malignant tumors, such as breast cancer [16], colorectal carcinoma [17, 18], glioma [19], renal cell carcinomas [20], prostate cancer [21], and lung cancer [22]. The gene discussed is YBX1; the disease is cancer.